The FDA has approved a combo antibiotic that targets complicated urinary tract infections caused by multidrug-resistant bacteria.
The findings underscore the need for more education as some sexually transmitted infections increase, the authors say.
New surveillance data show cases of gonorrhea, syphilis, and congenital syphilis have reached their highest levels in over a decade.
An observational study in California finds doxycycline post-exposure prophylaxis remains very effective against chlamydia and syphilis, but is not effective against gonorrhea.
Eastern Chad is facing dual outbreaks of measles and meningitis C as thousands flee conflict in neighboring Sudan.
Among gay and bisexual men with a history of gonorrhea infection who received either the 4CMenB vaccine or placebo, gonorrhea incidence was essentially the same—roughly 48% in both arms.
The European health agency says decisions on doxycycline post-exposure prophylaxis use should be made at the individual level, following clinical judgement and national guidelines.
Debio1453 is a first-in-class antibiotic candidate that targets an enzyme that’s essential for the growth of Neisseria gonorrhoeae.
Data on more than 1.4 millions incarcerated individuals in 43 countries shows STI rates are particularly high in adolescents and women.
The report is in response to a continent-wide surge in STIs since 2014.
